pharmaceutical-investing Mesoblast Licensee Files for Marketing Approval to Treat Epidermolysis Bullosa
Hercules Capital Provides US$15M From Existing Facility for Mesoblast to Accelerate Product Commercialization Programs
Mesoblast Reports First Quarter Ended September 30, 2018 Financial Results and Operational Highlights
Tilray Medical Strengthens Italian Market Presence with the Launch of Tilray Medical Italia and Expanded Medical Cannabis Portfolio
Kingfisher Confirms Blind Copper-Gold Porphyry Discovery at Hank, HWY 37 Project, Golden Triangle, British Columbia
Skyharbour Announces Major 2026 Exploration Campaign with Denison Mines at Russell Lake Uranium Joint Ventures
